Lead Paint Settlement Reached for $305M By Suppliers To Resolve Decades-Long Legal Battle

Several companies have agreed to pay $305 million to settle lead paint lawsuits brought by a number of California communities, resolving litigation that has dragged on for nearly 20 years and avoiding a prior award of $1.1 billion in damages.

The lead paint settlement was announced on Wednesday, in filings at Santa Clara County Superior Court. Sherwin-Williams, ConAgra Grocery Products Co. and NL Industries have agreed to fund a remediation program in communities across the state with older housing that contains lead paint. They will pay in installments, beginning with a $75 million payment later this year.

The case involved allegations that the paint suppliers knew how dangerous lead contained in their products was, but hid that data from the public. In 2014, a judge ordered the companies to pay $1.1 billion in damages. However, in 2017, another court ruled that they could only be held responsible for lead paint in housing that predates 1951.

Similar lawsuits against lead paint manufacturers have failed in most other states, including Illinois, Missouri, New Jersey, New York, Ohio, Rhode Island and Wisconsin.

The communities which will benefit from the settlement includes the counties of Alameda, Los Angeles, Monterey, San Mateo, Santa Clara, Solana, and Ventura. The cities of Oakland, San Diego and San Francisco are also included.

The U.S. Centers for Disease Control and Prevention (CDC) estimate that 535,000 children ages 1-5, or about 2.6% of such children in the U.S., have levels of lead in their blood that place them at risk for adverse health effects. To come up with that number, the CDC analyzed data from the National Health and Nutrition Examination Survey from the years 1999 to 2002, and 2007 through 2010.

Childhood lead poisoning is considered the most preventable environmental disease among young children. More than half a million children in the U.S, have lead blood levels above 5 micrograms per deciliter, the “level of concern” reference set by the CDC.


0 Comments


Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

MORE TOP STORIES

In the six months since a Bard hernia mesh settlement agreement was reached, at least two dozen new lawsuits have been brought, as the implants continue to fail and require revision surgery.
As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025.
Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case.